# SpineGuard

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/spineguard-s-a

- Industry: Medical Devices & Equipment
- Headquarters: Vincennes, France
- Website: www.spineguard.com
- Total disclosed funding: $13M
- Latest round: Series A (Sep 27, 2011)
- Investors on record: 6

## About

SpineGuard, S.A. specializes in advanced medical technology for spine surgery, focusing on enhancing safety and precision through innovative solutions that support surgical procedures.Founded in 2009 by Pierre Jerome and Stephane Bette, SpineGuard, S.A. is headquartered in Vincennes, France. The company designs and develops medical devices, with a focus on spine surgery. In April 2016, SpineGuard raised EUR 8.1 million in its initial public offering, and in June 2015, it secured EUR 1.55 million in a private placement. The most recent funding round was a PIPE in April 2013, where the company raised EUR 9.0 mn from investors including Harbert European Fund Advisors Ltd, Nice & Green SA, and Norgine Ventures, bringing the total amount raised to EUR 9.0 mn.SpineGuard specializes in advanced medical technology for spine surgery, with its flagship product, PediGuard®, utilizing Dynamic Surgical Guidance (DSG®) technology. This technology provides real-time feedback to surgeons, alerting them of potential breaches in the vertebral cortical wall during pedicle screw placement. The products are primarily distributed to hospitals and surgical centers across Europe, North America, and Asia, facilitating safer surgical procedures and reducing reliance on radiographic imaging.In the most recent year, 2023, SpineGuard reported revenue of EUR 3,228,279.20, while its EBITDA for the same year was EUR -1,978,921.80. The revenue is generated through direct sales of the PediGuard® devices and other related surgical products, primarily through B2B transactions with healthcare institutions.SpineGuard aims to enhance its product lineup by developing new innovations designed for spine surgery, although specific release dates are not available. The company is also focused on expanding into new geographic markets and regions. The funding raised in recent rounds will support these initiatives, particularly to facilitate broader market penetration and product development efforts.

## Funding rounds

- Series A, Sep 27, 2011, $6M — Delta Partners, Eurazeo, Omnes Capital, IPSA, Amundi, A Plus Finance
- Series A, May 12, 2009, $6.7M — Omnes Capital, IPSA, A Plus Finance

## Investors

- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series A
- IPSA (https://capitalatlas.ai/funds/ipsa) — Series A
- A Plus Finance (https://capitalatlas.ai/funds/a-plus-finance) — Series A
- Delta Partners (https://capitalatlas.ai/funds/delta-partners) — Series A
- Eurazeo (https://capitalatlas.ai/funds/eurazeo) — Series A
- Amundi (https://capitalatlas.ai/funds/amundi) — Series A